Patient value: its nature, measurement, and role in real world evidence studies and outcomes-based reimbursement

被引:15
|
作者
McKenna, Stephen P. [1 ,2 ]
Wilburn, Jeanette [1 ]
机构
[1] Galen Res Ltd, B1 Chorlton Mill,3 Cambridge St, Manchester M1 5BY, Lancs, England
[2] Univ Manchester, Sch Hlth Sci, Manchester, Lancs, England
关键词
Health-related quality-of-life; health service evaluation; needs-based quality-of-life; outcomes-based reimbursement; patient reported outcome measures; patient value; real world evidence; QUALITY-OF-LIFE; HEALTH; PSORIASIS; PSORIQOL; SCORES;
D O I
10.1080/13696998.2018.1450260
中图分类号
F [经济];
学科分类号
02 ;
摘要
The assessment of patient value is fundamental to clinical trials, real world evidence studies, and outcomes-based reimbursement schemes. Measures of health-related quality-of-life (HRQoL) are widely used in health research. Such measures are effective in determining the presence or absence of symptoms and functional ability. However, HRQoL measures were not intended, nor designed, to determine the value to patients of alternative health states. Functions have no intrinsic value-they are a means to fulfil human needs. However, needs can be met in a variety of ways, for example by adopting different functions or by the provision of social services. It is possible to analyze all functions in terms of the needs they satisfy. A needs model has been applied in health research since the 1990s. It is concerned with the extent to which human needs are fulfilled in the presence of disease and its treatment. It is argued that this is the major concern of the patient. Needs-based measures are patient-centric and produce a valid unidimensional index of outcome. Consequently, they provide a direct means of measuring patient value. This approach provides the possibility of evaluating health services in terms of the value they provide to consumers and payers. It also has a role to play in real-world evidence studies and outcomes-based reimbursement. It is recommended that greater attention is given in future to the development of patient-reported outcome measures that provide direct assessments of patient value.
引用
收藏
页码:474 / 480
页数:7
相关论文
共 50 条
  • [1] THE ROLE OF OUTCOMES-BASED MODELS FOR THE REIMBURSEMENT OF MEDICINES IN THE UK NATIONAL HEALTH SERVICE
    Armendariz, Y.
    Evans, C.
    Halliday, A.
    Walsh, J. J.
    VALUE IN HEALTH, 2019, 22 : S720 - S720
  • [2] Outcomes-Based Conditionality: Its Role and Optimal Design
    Anna Ivanova
    IMF Staff Papers, 2006, 53 (Suppl 1): : 76 - 91
  • [3] Outcomes-based conditionality: Its role and optimal design
    Ivanova, Anna
    IMF STAFF PAPERS, 2006, 53 : 76 - 91
  • [4] MARKET ACCESS AND REIMBURSEMENT: THE INCREASING ROLE OF REAL-WORLD EVIDENCE
    Pietri, G.
    Masoura, P.
    VALUE IN HEALTH, 2014, 17 (07) : A450 - A451
  • [5] Optimizing patient outcomes and reimbursement with evidence-based practice
    Beltz, Janice M.
    WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE, 2008, : 10 - 15
  • [6] Harnessing the patient voice in real-world evidence: the essential role of patient-reported outcomes
    Calvert, Melanie J.
    O'Connor, Daniel J.
    Basch, Ethan M.
    NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (10) : 731 - 732
  • [7] The rise of real world evidence and its role for technology
    Soer, Remko
    JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION, 2021, 34 (06) : 903 - 904
  • [8] REAL WORLD EVIDENCE COMPARING THE PATIENT REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM TO THE CDAI IN RHEUMATOID ARTHRITIS PATIENTS
    Curtis, J. R.
    Kafka, S.
    Parenti, D.
    Black, S.
    Xu, S.
    Wang, Y.
    Bingham, C. O., III
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 460 - 461
  • [9] Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma
    Orlowski, Robert Z.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (05): : 487 - 487
  • [10] Systematic review of guidance for the collection and use of patient-reported outcomes in real-world evidence generation to support regulation, reimbursement and health policy
    Maruszczyk, Konrad
    Aiyegbusi, Olalekan Lee
    Torlinska, Barbara
    Collis, Philip
    Keeley, Thomas
    Calvert, Melanie J.
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2022, 6 (01)